BIOEQUIVALENCE OF GENOTROPIN AND SOMATONORM

被引:0
|
作者
WILTON, P
WIDLUND, L
GUILBAUD, O
机构
[1] KABIVITRUM AB,RES & DEV,DEPT PHARMACOL,STOCKHOLM,SWEDEN
[2] KABIVITRUM AB,RES & DEV,DEPT STAT,STOCKHOLM,SWEDEN
[3] KABIVITRUM AB,RES & DEV,COMP SERV,STOCKHOLM,SWEDEN
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:118 / 121
页数:4
相关论文
共 50 条
  • [41] BIOEQUIVALENCE REVISITED
    SHEINER, LB
    STATISTICS IN MEDICINE, 1992, 11 (13) : 1777 - 1788
  • [42] Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence
    Laszlo Tothfalusi
    Laszlo Endrenyi
    Alfredo Garcia Arieta
    Clinical Pharmacokinetics, 2009, 48 : 725 - 743
  • [43] Individual bioequivalence - New concepts in the statistical assessment of bioequivalence metrics
    Patnaik, RN
    Lesko, LJ
    Chen, ML
    Wiliams, RL
    Balch, A
    Chan, K
    Machado, S
    Schuirmann, D
    Hauck, W
    Schall, R
    CLINICAL PHARMACOKINETICS, 1997, 33 (01) : 1 - 6
  • [44] Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence
    Tothfalusi, Laszlo
    Endrenyi, Laszlo
    Garcia Arieta, Alfredo
    CLINICAL PHARMACOKINETICS, 2009, 48 (11) : 725 - 743
  • [45] Bioequivalence of topical dermatological dosage forms - Methods of evaluation of bioequivalence
    Shah, VP
    Flynn, GL
    Yacobi, A
    Maibach, HI
    Bon, C
    Fleischer, NM
    Franz, TJ
    Kaplan, SA
    Kawamoto, J
    Lesko, LJ
    Marty, JP
    Pershing, LK
    Schaefer, H
    Sequeira, JA
    Shrivastava, SP
    Wilkin, J
    Williams, RL
    PHARMACEUTICAL RESEARCH, 1998, 15 (02) : 167 - 171
  • [46] Erratum to: Individual bioequivalence: new concepts in the statistical assessment of bioequivalence metrics
    R. N. Patnaik
    L. J. Lesko
    M. L. Chen
    Clinical Pharmacokinetics, 1997, 33 : 312 - 312
  • [47] Bioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of Bioequivalence
    Vinod P. Shah
    Gordon L. Flynn
    Avraham Yacobi
    Howard I. Maibach
    Charles Bon
    Nicholas M. Fleischer
    Thomas J. Franz
    Stanley A. Kaplan
    Jeff Kawamoto
    Lawrence J. Lesko
    Jean-Paul Marty
    Lynn K. Pershing
    Hans Schaefer
    Joel A. Sequeira
    Surendra P. Shrivastava
    Jonathan Wilkin
    Roger L. Williams
    Pharmaceutical Research, 1998, 15 : 167 - 171
  • [48] THE COST-EFFECTIVENESS OF GROWTH HORMONE REPLACEMENT THERAPY WITH GENOTROPIN® IN HYPOPITUITARY ADULT PATIENTS
    Bolin, K.
    Jonsson, B.
    Koltowska-Haggstrom, M.
    Prutz, C.
    Sandin, R.
    VALUE IN HEALTH, 2008, 11 (06) : A508 - A508
  • [49] The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden
    Bolin K.
    Sandin R.
    Koltowska-Häggström M.
    Loftus J.
    Prütz C.
    Jonsson B.
    Cost Effectiveness and Resource Allocation, 11 (1)
  • [50] Indicators of Evidence for Bioequivalence
    Morgenthaler, Stephan
    Staudte, Robert
    ENTROPY, 2016, 18 (08):